The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells - PubMed
- ️Fri Jan 01 1982
. 1982 Apr 10;257(7):3362-5.
- PMID: 6949902
Free article
The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells
R J Majeska et al. J Biol Chem. 1982.
Free article
Abstract
The effects of 1,25-dihydroxyvitamin D3 on growth, cell protein, and alkaline phosphatase were examined in cultures of a clonal osteoblast-like rat osteosarcoma cell line at different stages of phenotypic maturation, defined by the level of alkaline phosphatase activity. In "immature" cultures with low alkaline phosphatase specific activity, 1,25-dihydroxyvitamin D3 at 10(-8)-10(-7) M inhibited cell growth and elevated alkaline phosphatase activity; lower hormone concentrations had no effect. In cultures with higher alkaline phosphatase activity, the hormone had biphasic effects: at concentrations of 10(-8)-10(-7) M, 1,25-dihydroxyvitamin D3 inhibited growth and elevated alkaline phosphatase and total cell protein; however, lower hormone concentrations (10(-10) and 10(-9) M) reduced alkaline phosphatase activity. This effect was more pronounced in more "mature" cultures where half-maximum inhibition of alkaline phosphatase activity occurred near 10(-11) M. At this stage, the hormone caused a small increase in cell number. The data suggest that 1,25-dihydroxyvitamin D3 exerts differential effects on skeletal cells depending on their state of growth or maturation. This finding may offer new insights into the effects of 1,25-dihydroxyvitamin D3 on bone and may help resolve apparently conflicting experimental findings on the effects of the hormone on osteoblast-like cells in culture.
Similar articles
-
Grigoriadis AE, Petkovich PM, Rosenthal EE, Heersche JN. Grigoriadis AE, et al. Endocrinology. 1986 Aug;119(2):932-9. doi: 10.1210/endo-119-2-932. Endocrinology. 1986. PMID: 3015560
-
1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells.
Manolagas SC, Burton DW, Deftos LJ. Manolagas SC, et al. J Biol Chem. 1981 Jul 25;256(14):7115-7. J Biol Chem. 1981. PMID: 6941964
-
Mulkins MA, Manolagas SC, Deftos LJ, Sussman HH. Mulkins MA, et al. J Biol Chem. 1983 May 25;258(10):6219-25. J Biol Chem. 1983. PMID: 6189822
-
Spiess YH, Price PA, Deftos JL, Manolagas SC. Spiess YH, et al. Endocrinology. 1986 Apr;118(4):1340-6. doi: 10.1210/endo-118-4-1340. Endocrinology. 1986. PMID: 3485045
-
Manolagas SC, Spiess YH, Burton DW, Deftos LJ. Manolagas SC, et al. Mol Cell Endocrinol. 1983 Nov;33(1):27-36. doi: 10.1016/0303-7207(83)90054-0. Mol Cell Endocrinol. 1983. PMID: 6357897 Review.
Cited by
-
In vitro use of vitamin D3 metabolites: culture conditions determine cell uptake.
Puzas JE, Brand JS. Puzas JE, et al. Calcif Tissue Int. 1985 Sep;37(5):474-7. doi: 10.1007/BF02557829. Calcif Tissue Int. 1985. PMID: 2998574
-
Municio MJ, Traba ML. Municio MJ, et al. J Physiol Biochem. 2004 Sep;60(3):219-24. doi: 10.1007/BF03167032. J Physiol Biochem. 2004. PMID: 15700769
-
Kim RH, Li JJ, Ogata Y, Yamauchi M, Freedman LP, Sodek J. Kim RH, et al. Biochem J. 1996 Aug 15;318 ( Pt 1)(Pt 1):219-26. doi: 10.1042/bj3180219. Biochem J. 1996. PMID: 8761475 Free PMC article.
-
Kumegawa M, Ikeda E, Tanaka S, Haneji T, Yora T, Sakagishi Y, Minami N, Hiramatsu M. Kumegawa M, et al. Calcif Tissue Int. 1984 Jan;36(1):72-6. doi: 10.1007/BF02405296. Calcif Tissue Int. 1984. PMID: 6322941
-
Ishibe M, Nojima T, Ishibashi T, Koda T, Kaneda K, Rosier RN, Puzas JE. Ishibe M, et al. Calcif Tissue Int. 1995 Dec;57(6):430-5. doi: 10.1007/BF00301946. Calcif Tissue Int. 1995. PMID: 8581875
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical